| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.33 | 0.02 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.36 | 0.02 |